Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization

Diabetes Obes MetabPublished Population-based cohort study with Mendelian randomization

Main finding · Prevalent MetS per 1 SD serum magnesiumResult — go to the resultOdds ratio 0.90 95% CI 0.83–0.98

Authors' conclusion

Serum magnesium is associated with prevalent, but not incident MetS, and this effect is stronger in individuals with CKD. MR analysis implies a potential, albeit weak, causal role of magnesium in MetS.

Study context

Population
General population, KORA F4/FF4 study1,446 longitudinal
Participants
2,996 participants
Exposure
Serum magnesium
Outcome
Prevalent and incident metabolic syndrome (MetS) and its individual components
Methodological detailscross-sectional and longitudinal analyses, two-sample Mendelian randomization, stratified by chronic kidney disease (CKD)
  • Cross-sectional and longitudinal analyses
  • Two-sample Mendelian randomization
  • Stratified by CKD

Main finding

Prevalent MetS per 1 SD serum magnesium

Odds ratio

0.90

95% CI 0.83–0.98

Serum magnesium (1 SD)
OR 0.90 (95% CI 0.83–0.98)

Per 1 SD serum magnesium, as printed

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Prevalent MetS in individuals with CKD, per 1 SD serum magnesiumMore pronounced in CKD0.75 (0.59–0.94)

Elevated fasting glucose (metabolic syndrome (MetS) component)

OR (95% CI)
Serum magnesiumNegative association0.78 (0.71–0.88)

Elevated fasting glucose in individuals with CKD

OR (95% CI)
Serum magnesiumMore pronounced in CKD0.67 (0.53–0.84)

Causal effect of serum magnesium on MetS (two-sample Mendelian randomization (MR))

OR (95% CI)
Serum magnesiumInverse causal effect suggested0.91 (0.85–0.97)

Incident MetS and its components (longitudinal)

Serum magnesium was not associated with incident MetS or its components

Nonlinearity (restricted cubic splines)

Significant nonlinear inverse relationship of serum magnesium with MetS and elevated fasting glucose

Original publication

Association of serum magnesium with metabolic syndrome and the role of chronic kidney disease: A population‐based cohort study with Mendelian randomization. Diabetes Obes Metab. Published 16 February 2024. doi:10.1111/dom.15497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.